NASDAQ · Key Statistics

Clearside Biomedical, Inc. (CLSD) Key Statistics

$0.41 NASDAQ: CLSD Market Cap $2.15M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Clearside Biomedical, Inc. (CLSD), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.11
P/B ratioShare price divided by book value per share.	-0.04
P/S ratioMarket value divided by annual revenue.	0.71
PEG ratioP/E divided by the earnings growth rate.	0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	0.43
EV / RevenueEnterprise value against annual revenue.	-1.39
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-909.09%
Free cash flow yieldFree cash flow as a percentage of market value.	-747.41%
Price / free cash flowMarket value divided by free cash flow.	-0.13

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	89.02%
Operating marginRevenue left after operating costs.	-523.09%
Net marginRevenue left after every cost, including tax and interest.	-618.26%
Return on equityProfit as a percentage of shareholders’ equity.	37.73%
Return on assetsProfit as a percentage of total assets.	-160.55%
Return on capital employedOperating profit against the capital the business uses.	-178.25%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	2.98
Quick ratioThe same, excluding inventory.	2.98
Cash ratioCash alone against current liabilities.	4.00
Debt to equityTotal borrowings against shareholders’ equity.	-0.01
Debt to assetsTotal borrowings against total assets.	2.08
Interest coverageHow many times operating profit covers the interest bill.	-1.98

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-7.05
Book value per shareShareholders’ equity divided by shares outstanding.	$-10.31
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$2.15M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$34.15M

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Clearside Biomedical, Inc. (CLSD) statistics — frequently asked questions

What is Clearside Biomedical, Inc.'s P/E ratio?

Clearside Biomedical, Inc. (CLSD) trades on a price-to-earnings ratio of -0.11. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Clearside Biomedical, Inc.'s return on equity?

Clearside Biomedical, Inc. (CLSD) reports a return on equity of 37.73%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Clearside Biomedical, Inc. carry?

Clearside Biomedical, Inc. (CLSD) has a debt-to-equity ratio of -0.01, which compares total borrowings with shareholders' equity.

What is Clearside Biomedical, Inc.'s profit margin?

Clearside Biomedical, Inc. (CLSD) keeps -618.26% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.